HUMAW vs LH
Humacyte Inc (HUMAW) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Humacyte Inc (HUMAW) common stock listed on NASDAQ.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
HUMAW does not have a complete income-statement cache yet.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
HUMAW currently screens at market cap $0. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the HUMAW and LH stock pages for the full models.
Not investment advice.